Literature DB >> 7819076

Treatment of chronic childhood immune thrombocytopenic purpura with intramuscular anti-D immunoglobulins.

C Borgna-Pignatti1, L Battisti, M Zecca, F Locatelli.   

Abstract

Seven patients with chronic immune thrombocytopenic purpura (ITP) were treated with intramuscular anti-D (anti-D IgG) five times, on an alternate-day basis, or until a platelet count of 100 x 10(9)/l was achieved, and, subsequently, when necessary to maintain platelet counts above 50 x 10(9)/l. Five patients responded to therapy, two of whom entered long-term remission. Although signs of haemolysis were present in all patients, anaemia was never a problem. No patient developed haematomas at the site of injection. We suggest that intramuscular anti-D represents a safe and relatively inexpensive alternative to intravenous gamma globulins (IVGG) for children with severe chronic ITP.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7819076     DOI: 10.1111/j.1365-2141.1994.tb05083.x

Source DB:  PubMed          Journal:  Br J Haematol        ISSN: 0007-1048            Impact factor:   6.998


  3 in total

Review 1.  [Chronic idiopathic thrombocytopenic purpura. Current therapy concept and introduction to pathophysiologic, clinical and diagnostic aspects].

Authors:  A Böcher; F G Hagmann; H Kreiter
Journal:  Med Klin (Munich)       Date:  1998-12-15

Review 2.  The thrombocytopenic purpuras. Recognition and management.

Authors:  S Gillis
Journal:  Drugs       Date:  1996-06       Impact factor: 9.546

3.  Anti-RhD immunoglobulin in the treatment of immune thrombocytopenia.

Authors:  Eric Cheung; Howard A Liebman
Journal:  Biologics       Date:  2009-07-13
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.